<bill session="105" type="h" number="3139" updated="2013-07-14T18:50:41-04:00">
  <state datetime="1998-02-03">REFERRED</state>
  <status>
    <introduced datetime="1998-02-03"/>
  </status>
  <introduced datetime="1998-02-03"/>
  <titles>
    <title as="introduced" type="short">Stop Medicare Overpayment Act of 1998</title>
    <title as="introduced" type="official">To amend title XVIII of the Social Security Act to stop overpayment for drugs and biologicals under the Medicare Program.</title>
  </titles>
  <sponsor id="400026"/>
  <cosponsors>
    <cosponsor id="401033" joined="1998-02-03"/>
    <cosponsor id="400048" joined="1998-03-11"/>
    <cosponsor id="400050" joined="1998-02-03"/>
    <cosponsor id="400578" joined="1998-02-26"/>
    <cosponsor id="400093" joined="1998-02-03"/>
    <cosponsor id="400103" joined="1998-02-03"/>
    <cosponsor id="400133" joined="1998-02-03"/>
    <cosponsor id="400143" joined="1998-02-03"/>
    <cosponsor id="404375" joined="1998-02-26"/>
    <cosponsor id="400240" joined="1998-02-03"/>
    <cosponsor id="400529" joined="1998-06-09"/>
    <cosponsor id="400263" joined="1998-03-11"/>
    <cosponsor id="400291" joined="1998-02-03"/>
    <cosponsor id="400309" joined="1998-02-03"/>
    <cosponsor id="400316" joined="1998-02-03"/>
    <cosponsor id="400358" joined="1998-02-03"/>
    <cosponsor id="300087" joined="1998-02-03"/>
    <cosponsor id="400378" joined="1998-02-03"/>
    <cosponsor id="400387" joined="1998-02-03"/>
    <cosponsor id="400389" joined="1998-02-03"/>
    <cosponsor id="400395" joined="1998-02-03"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="1998-02-03">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="1998-02-03">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="1998-02-03">
      <text>Referred to House Commerce</text>
    </action>
    <action datetime="1998-02-04">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR H302-303"/>
    </action>
    <action datetime="1998-02-05">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Ways and Means"/>
    </action>
    <action datetime="1998-02-11">
      <text>Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.</text>
      <committee name="House Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM02" subcommittee="Health" name="House Ways and Means"/>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Commerce"/>
    <term name="Drugs"/>
    <term name="Medical fees"/>
    <term name="Medicare"/>
    <term name="Prescription pricing"/>
    <term name="Social welfare"/>
  </subjects>
  <amendments/>
  <summary>2/3/1998--Introduced.
Stop Medicare Overpayment Act of 1998 - Amends title XVIII (Medicare) of the Social Security Act, as amended by the Balanced Budget Act of 1997, with respect to reimbursement for drugs and biologicals. Replaces the current reimbursement rate of 95 percent of the wholesale average price with the lowest of the following: (1) the current rate; (2) the actual acquisition cost to the claim submitter of the drug or biological; (3) the amount otherwise determined under Medicare part B (Supplementary Medical Insurance); or (4) for payments for drugs or biologicals furnished on or after January 1, 2000, the median actual acquisition cost of all claims for payment for such drugs or biologicals for the 12-month period beginning July 1, 1998.</summary>
</bill>
